TCMD · Tactile Systems Technology
The AI's read
The stronger profit forecast reflects the strength of Tactile's main lymphedema business. That business has grown by double digits for 5 straight quarters, and the share of sales left after product costs has grown for 12 straight quarters. Airway-clearance sales fell as distributors worked through excess inventory. Tactile expects that business to decline for the full year, but expects it to improve in Q4. The strong lymphedema business and higher profit forecast make the report favorable overall.